Está en: COF > Recursos Profesionales > Alertas en medicamentos Miércoles, 10 de marzo de 2010  
Enlaces de interés
Noticias y Alertas
Alertas farmacológicas científicas
Alertas en medicamentos
Novedades en Prensa y Agencia

Alertas en medicamentos

Novedades de hoy, 10 de marzo de 2010 en

Taro Receives FDA Approval for Fluorouracil Topical Cream USP, 5%
Taro Pharmaceuticals USA [traducción]
Bayer CropScience and Mendel Biotechnology expand collaboration in crop protection
BayNews International [traducción]
Acura Pharmaceuticals and King Pharmaceuticals Announce Positive Top Line Results of a Clinical Study Assessing Relative Abuse Potential
King Pharmaceuticals [traducción]
Validation of the American Thoracic Society-Infectious Diseases Society of America Guidelines for Hospital-Acquired Pneumonia in the Intensive Care Unit
Clinical Infectious Diseases [traducción]
Bristol-Myers Squibb to Present at Cowen and Company Health Care Conference
Bristol Myers-Squibb Company [traducción]
GSK CEO Andrew Witty dedicates albendazole facility in Nashik to WHOs Global Programme to Eliminate LF
GlaxoSmithKline [traducción]
Nabi Biopharmaceuticals to Announce 2009 Fourth Quarter and Year-End Financial Results on March 2010
Nabi Biopharmaceuticals [traducción]
Teva to Present at the Cowen and Company 30th Annual Healthcare Conference
Teva Pharmaceutical Industries [traducción]
Adolor Corporation Presentation at the Cowen and Company 30th Annual Health Care Conference Rescheduled on March 2010
Adolor Corporation [traducción]
Human genome sciences invites investors to listen to webcast of presentation at the cowen and company health care conference
Human Genome Sciences [traducción]
Bayer Helps Victims of Earthquake in Chile
BayNews International [traducción]
ADVANCE-2 Study Results Demonstrate Investigational Anticoagulant Apixaban Was Statistically Superior to Enoxaparin in the Prevention of Venous Thromboembolism Following Knee Replacement Surgery
Bristol Myers-Squibb Company [traducción]
New Brunswick to acquire four new MRI scanners
Canadian Healthcare Technology [traducción]
Fourth quarter and full year report 2009 - Lundbeck delivers 22 percent revenue growth for 2009 and meets financial expectations for 2009
Lundbeck [traducción]
Bristol-Myers Squibb to Highlight Strong Pipeline and Execution of BioPharma Strategy in Meeting with Investment Community
Bristol Myers-Squibb Company [traducción]
Gilead Sciences to Present at the Cowen and Company 30th Annual Health Care Conference on March
Gilead [traducción]
Ncqa honors health quality leaders, celebrates 20 years of improving health care quality
National Committee for Quality Assurance (NCQA) [traducción]
Bristol-Myers Squibb and Allergan Enter Global Agreement on Investigational Neuropathic Pain Medicine
Bristol Myers-Squibb Company [traducción]
Lundbeck and Takeda finalise plans to initiate phase III pivotal clinical trials with Lu AA21004 and Lu AA24530
Lundbeck [traducción]
Repligen Announces Acquisition of Chromatography Technology Platform Plug and Play Products Create Broad Opportunity in Biopharmaceutical Manufacturing
Repligen [traducción]
AstraZeneca recognized for support of women executives
AstraZeneca [traducción]
Project Runways Tim Gunn Returns to Address Psoriasis(TM) and Empower Patients to be Confident in Their Personal Style
Amgen [traducción]
PTC Therapeutics and Genzyme Corporation Announce Preliminary Results from the Phase 2b Clinical Trial of Ataluren for Nonsense Mutation Duchenne/Becker Muscular Dystrophy
Genzyme [traducción]
Adolor Corporation to Present at the Cowen and Company 30th Annual Health Care Conference
Adolor Corporation [traducción]
Angiotech Pharmaceuticals, Inc. Announces Financial Results for the Fourth Quarter Ended December 2009
Angiotech Pharmaceuticals [traducción]
Bristol-Myers Squibb Names Lamberto Andreotti CEO, Effective May 4; James Cornelius to Retire as CEO, Remain as Chairman
Bristol Myers-Squibb Company [traducción]
Bristol-Myers Squibb Announces Dividend
Bristol Myers-Squibb Company [traducción]
Human genome sciences announces fourth-quarter and full-year 2009 financial results and key developments
Human Genome Sciences [traducción]

Si desea visualizar novedades previas, localice el día y presione

 

  © 2010. Medlinet.com. Todos los derechos reservados